NuFund Venture Group

Resolute is creating a new class of medicines for aggressive solid tumors that are uncommon and challenging to treat. Founded with the goal of curing solid tumors, Resolute uses the technology platform of MAC-TACs (Macrophage Targeted Conjugates) to develop a wide range of biomarker-driven, first-in-class, synthetic molecules that are potentially safer and more effective than current standard of care for pan-cancer patients.

Alt Sports Data specializes in providing proprietary data and odds for the gaming and wagering sectors, focusing on emerging and non-mainstream sports. The company acts as a vital link between alternative sports and the gaming industry, offering comprehensive access to sports trading and customer data. By leveraging specialist-managed trading systems, Alt Sports Data enables its clients, including sports leagues, technology platforms, and regulated sportsbooks, to engage with a variety of top-line, derivative, and propositional markets. This approach aims to enhance the market experience and expand audience reach within the sports ecosystem.

Vasa Therapeutics is a privately held, preclinical-stage biopharmaceutical company based in Encinitas, California. The company focuses on developing therapies for various vascular diseases, including heart failure, peripheral artery disease, and sarcopenia. Vasa Therapeutics employs a comprehensive platform for drug discovery, allowing for the identification and development of small molecule or peptide therapeutics. This in-house testing funnel enables healthcare professionals to efficiently evaluate potential treatments, aiming to improve outcomes for patients suffering from vascular conditions.

Kneevoice is a company focused on advancing knee health and wellness through its innovative digital patellofemoral audio-arthrography system. Founded in 2015 and based in Santa Monica, California, the company integrates a sophisticated sound acquisition system with cloud-based machine-learning algorithms. This technology allows for prompt and efficient diagnostic accuracy, which was previously attainable only through non-dynamic, non-specific, or invasive testing methods. By utilizing wearable devices, Kneevoice enables patients to monitor and maintain their knee health effectively.

PrivacyHawk is a consumer privacy platform that empowers individuals to manage their personal data effectively. The company provides an automated solution for opting out, unsubscribing, and deleting personal information from numerous databases that may exploit clients' data. By streamlining these processes, PrivacyHawk helps users reduce their digital footprint and enhance their privacy, thereby lowering the risks associated with scams, spam, and identity theft. The platform focuses on enabling individuals to regain control over their private information, promoting a safer online experience.

Cooler Heads is a company that specializes in developing portable scalp cooling systems specifically for chemotherapy patients. Its flagship product, Amma™, is designed to help individuals undergoing cancer treatment maintain their hair, thereby enhancing their sense of identity and control during a challenging time. By cooling the scalp, the system aims to reduce hair loss associated with chemotherapy, allowing patients to manage the physical side effects of treatment more effectively. This approach not only addresses the cosmetic concerns of hair loss but also positively impacts patients' mental health and overall recovery by supporting their emotional well-being throughout the treatment process.

Duo Oncology is a biotechnology company focused on developing innovative nanoparticle technology designed to penetrate established tumors, particularly targeting hard-to-treat cancers such as pancreatic cancer and bile duct cancer. By collaborating closely with leading university scientists and medical oncologists, Duo Oncology aims to redefine treatment outcomes through a novel monotherapy approach that enhances patient care. The company's research is supported by a network of established research organizations, enabling efficient and rapid development of its products. With a commitment to advancing immunotherapy and precision medicine, Duo Oncology seeks to improve recovery times and overall treatment efficacy for patients facing challenging diagnoses.

KeepWOL is a developer of a talent development platform that focuses on enhancing team collaboration and fostering inclusion across remote, hybrid, and in-person teams. The company's software offers a comprehensive library of content, facilitation training, and ongoing support designed to facilitate cultural transformation and team building. By providing insightful learning and development resources, KeepWOL enables organizations to create guided immersive experiences that promote employee development and engagement. The platform combines the human element with data and artificial intelligence to deliver real-time feedback and actionable insights, helping teams identify critical growth opportunities and improve overall organizational health. Through its innovative approach, KeepWOL aims to strengthen team dynamics and enhance execution within organizations.